Literature DB >> 21252539

IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi.

Nasim Mansoori1, Manjari Tripathi, Rizwan Alam, Kalpana Luthra, Lakshmy Ramakrishnan, Shama Parveen, Asok K Mukhopadhyay.   

Abstract

BACKGROUND: Remarkable improvement in the life expectancy of the Indian population is expected to commensurate with the increase in number of dementia cases. Among various types of dementia, Alzheimer's disease (AD) and vascular dementia (VaD) are common and widely studied. We evaluated the role of apolipoprotein E (ApoE) and interleukin-6 (IL-6)-174 G/C gene polymorphism along with serum IL-6 levels in AD and VaD patients.
METHODS: The polymorphisms in ApoE and IL-6-174 G/C genes were assessed using RFLP. Serum IL-6 level was measured by ELISA.
RESULTS: The allele ε4 of the ApoE gene was found to be associated with AD and VaD patients (p < 0.05). No association of IL-6-174 G/C polymorphism was observed in AD patients, while the IL-6-174 C allele increased the odds of having VaD twofold. Regression analysis to assess possible interaction between ApoE and the IL-6-174 G/C genes revealed that presence of both the ε4 and C alleles increased the odds of having AD 13.75-fold and VaD 14.7-fold. Serum IL-6 levels did not correlate with either presence or severity of disease among AD or VaD patients.
CONCLUSION: The ApoE ε4 allele is an important genetic marker for AD and VaD. Presence of both ApoE ε4 and IL-6 C genes increases the OR of having AD and VaD markedly.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252539     DOI: 10.1159/000321666

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  6 in total

Review 1.  Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.

Authors:  Limeng Dai; Dan Liu; Hong Guo; Yanyan Wang; Yun Bai
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

Review 2.  Stroke Risk and Vascular Dementia in South Asians.

Authors:  Vineeta Singh; Mandip S Dhamoon; Suvarna Alladi
Journal:  Curr Atheroscler Rep       Date:  2018-07-05       Impact factor: 5.113

3.  IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease.

Authors:  Hui-Ping Qi; Zheng-Yi Qu; Shu-Rong Duan; Shu-Qin Wei; Shi-Rong Wen; Sheng Bi
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

Review 4.  Changing demography and the challenge of dementia in India.

Authors:  Vijayalakshmi Ravindranath; Jonas S Sundarakumar
Journal:  Nat Rev Neurol       Date:  2021-10-18       Impact factor: 42.937

5.  Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.

Authors:  Stanislav Sutovsky; Robert Petrovic; Maria Fischerova; Viera Haverlikova; Barbara Ukropcova; Jozef Ukropec; Peter Turcani
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.

Authors:  Bo Ding; Chengheng Lin; Qian Liu; Yingying He; John Bosco Ruganzu; Hui Jin; Xiaoqian Peng; Shengfeng Ji; Yanbing Ma; Weina Yang
Journal:  J Neuroinflammation       Date:  2020-10-14       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.